Melanotan 2 Effects & Safety: What People Report, Read Honestly

The short version

People use Melanotan 2 mainly to tan fast with little sun. Most also notice it kills their appetite, and many men get a strong, often unprompted, sex drive. Those are the draws. The trade-offs that come with them are nausea, facial flushing, a run-down feeling, and — the one that sends people to a doctor — moles that darken or appear new.

This page does two things and keeps them apart. First, what users themselves report — useful, but anecdotal and uncontrolled. Second, what the published medical literature has documented: the serious case reports of prolonged painful erections, muscle and kidney injury, and melanoma, plus the reasons doctors and regulators warn against it. Melanotan 2 is approved nowhere, and nothing here is a dose or an instruction — it is a plain reading of effects and risks.

What people report

These are effects reported by the research-use community and in published surveys of online discussion — anecdotal, not clinical evidence, and not verified by controlled trials. They are described here plainly and without any doses, because an honest review names what people actually experience.

Benefits people seek

• A rapid, deep tan with little or no sun. Very commonly reported as the entire reason for use: skin darkening within days, and a deeper color reached with far less sun or sunbed time than otherwise ^[22].
• Reduced appetite, and sometimes weight loss. Very commonly reported, often from the first dose — a marked drop in hunger within the first hour, with some describing weight loss ^[22].
• Higher libido and spontaneous erections (men). Commonly reported by men, often beginning with the first or second dose: a sudden surge in sex drive and unprompted erections. Women also report heightened arousal ^[22].
• Cosmetic satisfaction and confidence. Commonly cited as the reason people continue despite side effects; some discussions note it can shade into preoccupation with appearance ^[22].

The unpleasant and the worrying

• Nausea, sometimes vomiting. Very commonly reported, typically within the first hour and worst in the early days, often easing as use continues ^[22].
• Facial flushing and feeling hot. Commonly reported soon after a dose — the face going red and warm, usually short-lived ^[16].
• Fatigue and lethargy — the 'melanotan flu.' Commonly reported when starting out: a run-down, flu-like tiredness bundled with nausea ^[22].
• Spontaneous stretching and yawning. Frequently reported soon after a dose; described as odd but harmless ^[22].
• Darkening of existing moles and freckles. Very commonly reported, often the first visible sign of activity, with spots standing out sharply ^[16].
• New moles appearing. A frequent and alarming report among longer-term users — brand-new spots, sometimes many at once, which is often what prompts a doctor visit ^[16].
• Uneven, blotchy, or unnaturally long-lasting tan. Frequently reported as a downside that builds over time, with patchy color, an orange or grey cast, and pigment lingering for weeks to months after stopping ^[22].
• Darkening of lips, gums, scars, and genital skin, and injection-site reactions (redness, swelling, small lumps), are also commonly reported ^[16].

A recurring user belief is that the deeper color protects against burning. Treat this as a belief, not a demonstrated protection — many still report burning when sun exposure is overdone ^[22]. None of the above is a controlled finding; the cited safety section below is where the documented medical evidence lives.

Safety & cautions

Each caution below is grounded in the published literature and cited. These are documented associations and mechanism-based concerns, not a complete or quantified risk profile.

New, changing, or darkening moles, and melanoma risk. As a non-selective melanocortin agonist acting on MC1R, Melanotan 2 drives melanocyte activity throughout the skin. Case reports describe eruptive new nevi, dysplastic (atypical) moles, and darkening of existing moles after use ^[16][20], and dermoscopy studies show measurable changes in melanocytic lesions during use ^[21]. Multiple case reports document melanoma and melanoma in situ arising in users ^[25][26]. The long-term melanoma risk is not established, but any new or changing mole during or after use warrants prompt dermatological assessment, especially alongside UV or sunbed exposure ^[27].

Rhabdomyolysis and acute kidney injury. A published case links Melanotan 2 injection to systemic toxicity with rhabdomyolysis — severe muscle breakdown that can poison the kidneys ^[17] — and a separate case with literature review describes renal infarction associated with its use, proposing both thrombotic and direct toxic mechanisms ^[4]. These indicate potential for serious muscle and kidney injury that is not fully understood.

Priapism — a prolonged, painful erection. Because melanocortin agonism promotes erections, several case reports describe priapism following melanotan tanning injections, including after apparent overdose ^[18][19][24]. Priapism is a urological emergency that can cause permanent damage if not treated quickly.

Posterior reversible encephalopathy syndrome (PRES). A case report describes PRES — a neurological condition involving brain swelling that can present with headache, seizures, visual disturbance, and high blood pressure — in association with melanotan use ^[23], consistent with the compound's reported effects on blood pressure and vascular tone.

Nausea and cardiovascular (pressor) effects. Preclinical work on the hemodynamic actions of alpha-MSH analogs shows melanocortin agonists can raise blood pressure, an effect worsened in animals by impaired nitric-oxide signaling ^[28][29]. Together with the very commonly reported nausea, this points to meaningful cardiovascular and gastrointestinal effects that are poorly characterized in humans using unregulated product.

Unregulated product — contamination and unknown content. Analytical studies of melanotan products bought online repeatedly find inaccurate labeling, variable or unverifiable peptide content, and impurities, and the compound appears in surveys of falsified injectables ^[30][31][32]. With no quality control, a buyer cannot know the actual identity, dose, purity, or sterility of what is in the vial — which compounds every other risk.

No approval, unknown long-term safety, and not a substitute for approved drugs. Melanotan 2 has never been approved by any regulator, and development did not complete late-phase trials, so long-term human safety is unknown; regulators and dermatology bodies have specifically warned against it ^[33][34]. It is sometimes confused with afamelanotide (an approved melanocortin therapy for erythropoietic protoporphyria) and with the separately approved sexual-function melanocortin agonist derived from this family — but those approvals and their trial-safety data do not extend to Melanotan 2 ^[35][36].

Then and now

Melanotan 2 was designed in the late 1980s as a superpotent analog of alpha-MSH, intended to promote tanning and photoprotection and so potentially reduce skin-cancer risk ^[33]. Early human work — including a pilot Phase I study — showed it could darken skin, and the observation that it also triggered erections led both to a small study in men with erectile dysfunction and to the development of the spin-off agonist bremelanotide (PT-141) for sexual dysfunction ^[2][36].

The original tanning program never reached the market. From the mid-2000s an illicit trade emerged, selling the peptide online as unlicensed 'sun-tan jabs' or the 'Barbie drug' despite repeated warnings from regulators and dermatologists ^[4][37]. It has never held a sanctioned medical or cosmetic use, and it remains an unapproved research chemical today ^[33].